Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A
tungsten
-binding protein was purified from a plasma membrane preparation of the iron-oxidizing bacterium, Acidithiobacillus ferrooxidans AP19-3 in an electrophoretically homogenous state. The protein was composed of two subunits with apparent molecular masses of 12 and 20.7 kDa. The molecular mass of the native protein was estimated to be 26.4 kDa in the presence of 1.5% 1-o-octyl-D -glucopyranoside (OGL), indicating that the native
tungsten
-binding protein is a heterodimeric protein. The amounts of
tungsten
bound to 1 mg of plasma membranes of A. ferrooxidans AP19-3 and the purified
tungsten
-binding protein at pH 3.0 were 191 and 1506 mug, respectively. In contrast, the amounts of
tungsten
bound to 1 mg of albumin,
aldolase
, catalase, chymotrypsinogen A, ferritin, and ferredoxin at pH 3.0 were 13.1, 18.6, 12.8, 16.6, 11.4, and 6.1 mug, respectively. Incubation of the
tungsten
-binding protein for 1 h with 10 mM Na(2)WO(4) plus 10 mM metal ion, such as NaVO(3), Na(2)MoO(4), CuSO(4), NiSO(4), MnSO(4), CoSO(4), or CdCl(2), did not markedly affect the amount of
tungsten
bound to the
tungsten
-binding protein, suggesting that the protein specifically binds
tungsten
.
...
PMID:Existence of a tungsten-binding protein in Acidithiobacillus ferrooxidans AP19-3. 1623 46